Sichuan Kelun Pharmaceutical Co Ltd Class A 002422
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 32.83
- Day Range
- CNY 32.58–34.64
- 52-Week Range
- CNY 21.60–34.64
- Bid/Ask
- CNY 33.93 / CNY 33.95
- Market Cap
- CNY 54.37 Bil
- Volume/Avg
- 23.1 Mil / 17.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 18.57
- Price/Sales
- 2.37
- Dividend Yield (Trailing)
- 1.81%
- Dividend Yield (Forward)
- 1.81%
- Total Yield
- 1.81%
Company Profile
Sichuan Kelun Pharmaceutical Co Ltd is a China-based Pharmaceutical company mainly focused on the production and sales of injection products, including products for glucose injection and sodium chloride injection. It manufactures and sells high-volume injections (infusions), small-volume injections (water needles), sterile powder injections (containing powdered and freeze-dried powder). Its products include tablets, capsules, capsules, granules, oral liquids, peritoneal dialysis fluids, raw material medicines, medical packaging materials, medical instruments, and antibiotic intermediates.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Core
- Total Number of Employees
- 18,422
- Website
- http://www.kelun.com
Comparables
Valuation
|
Metric
|
002422
|
002907
|
002900
|
|---|---|---|---|
Price/Earnings (Normalized) | 18.57 | 203.70 | 307.65 |
Price/Book Value | 2.44 | 3.64 | 1.45 |
Price/Sales | 2.37 | 8.23 | 2.82 |
Price/Cash Flow | 10.27 | 46.82 | — |
Price/Earnings
002422
002907
002900
Financial Strength
|
Metric
|
002422
|
002907
|
002900
|
|---|---|---|---|
Quick Ratio | 1.43 | 4.02 | 1.08 |
Current Ratio | 1.98 | 5.05 | 1.36 |
Interest Coverage | 15.05 | — | 2.29 |
Quick Ratio
002422
002907
002900
Profitability
|
Metric
|
002422
|
002907
|
002900
|
|---|---|---|---|
Return on Assets (Normalized) | 7.09% | 1.56% | 1.15% |
Return on Equity (Normalized) | 13.68% | 1.80% | 1.88% |
Return on Invested Capital (Normalized) | 9.30% | 1.41% | 1.33% |
Return on Assets
002422
002907
002900
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Bvkztysc | Cfd | $718.4 Bil | |
JNJ
| Johnson & Johnson | Rlbxqgf | Xvhh | $360.8 Bil | |
MRK
| Merck & Co Inc | Sxsdhmvw | Lrjq | $326.3 Bil | |
ABBV
| AbbVie Inc | Qsbdwvfd | Nltjt | $286.3 Bil | |
AZN
| AstraZeneca PLC ADR | Dxdrzfvyv | Pbttc | $235.6 Bil | |
NVS
| Novartis AG ADR | Dkrhnqtm | Wkbv | $197.6 Bil | |
RHHBY
| Roche Holding AG ADR | Knysmmjfr | Dbh | $193.6 Bil | |
PFE
| Pfizer Inc | Grzlpsvd | Dpgq | $153.9 Bil | |
AMGN
| Amgen Inc | Xtgjmqvjy | Dghg | $149.3 Bil | |
SNY
| Sanofi SA ADR | Sxztdmkzh | Lpx | $123.9 Bil |